An Illinois-based pharmacy group is leading the charge for an antimicrobial therapy timeout initiative, in response to a joint commission mandate. Read More »

The National Institute of Allergy and Infectious Diseases recently released new guidelines to help health care providers and family members manage and prevent peanut allergies in infants. Read More »

A new trend in communications is on the verge of creating a health care revolution, according to one rehabilitation clinic spokesperson. Read More »

A recent study has shown that medical home care model as increased overall primary care of patients, and has reduced overall health care cost. Read More »

At the touch of a fingertip, Cigna enrollees can now track health information, find practitioners and manage claims, all via their digital devices, with the company’s recent installation of personalized fingerprint access to their accounts. Read More »

Iroko Pharmaceuticals LLC, a company focused on advancing the science of analgesia, recently received a patent for VIVLODEX (meloxicam) capsules 5 mg and 10 mg. Read More »

RxWiki Inc. has launched Patient Verified Reviews, a platform that allows patients to rate their pharmacy. Read More »

The pharmaceutical research company TPD LLC (Trends in Pharma Development) recently announced its new line of PanX medicines for use in treating anxiety. The products will be available nationwide as prescription compounded drugs. Read More »

Medinol, a global Interventional Cardiology device company, recently announced positive twelve-month clinical results from its BIONICS study. The study was conducted to analyze and evaluate EluNIR, the company’s coronary stent system and the first ever elastomer-coated drug eluting stent (eDES). Read More »

Intrarosa (prasterone), which is designed for women who experience moderate to severe pain during sex, has been approved by the U.S. Food and Drug Administration. Read More »

Alcon, a worldwide leader in eye care and a Novartis division, has released its Online Toric IOL Calculator, which was developed for the use of cataract surgeons who are treating patients with corneal astigmatism. Read More »

Mylan N.V. and Biocon Ltd. released results of their Heritage Study in the Journal of the American Medical Association, showing positive indications for MYL-1401O, the proposed biosimilar trastuzumab co-developed by Mylan and Biocon. Read More »

Concert Pharmaceuticals' Phase 2 clinical trial taking place in the United States and involving CTP-656, also known as deuterated ivacaftor, has been initiated. Read More »

Portola Pharmaceuticals has signed a $50 million loan agreement with Bristol-Myers Squibb and Pfizer that gives Portola supplementary funds to allow for the development and clinical trials of AndexXa. Read More »

Integrated Delivery Networks are continuing to form with the continued growth and mergers of health systems. Read More »

Ionis Pharmaceuticals posted earnings of $28 million from AstraZeneca due to the finalization of AstraZeneca’s studies supporting IND and the licensing of IONIS-KRAS-2.5Rx, also known as AZD4785. Read More »

Express Scripts' enhancements have been applied to its SafeGuardRx programs, which focus on the treatment of hepatitis C and cancer. Read More »

A Walgreens study conducted in collaboration with the Scripps Translational Science Institute demonstrated that long-term health engagement can be meaningfully improved by automated health tracking. Read More »

Pfizer will expand its Advancing Science through Pfizer Investigator Research Exchange program next year. Read More »

Baxter International Inc. recently announced the recipients of its seventh annual Leadership Excellence Awards in Pharmacy at the American Society of Health-System Pharmacists 2016 Midyear Meeting. Read More »